[1] 原研说明书.[2] Chen R , Wang H , Zhong W , et al. A phase 1 pharmacokinetic study of oral NEPA, the fixed combination of netupitant and palonosetron, in Chinese healthy volunteers[J]. Cancer Chemotherapy and Pharmacology, 2021, 87(3):1-10.[3] Calcagnile S , Lanzarotti C , Gutacker M , et al. Evaluation of the effect of food and age on the pharmacokinetics of oral netupitant and palonosetron in healthy subjects: A randomized, open-label, crossover phase 1 study.[J]. Clinical Pharmacology in Drug Development, 2015, 4(5):377-386.
